Cetuximab Terminated Phase 1 Trials for Malignant Neoplasm of Colon / Rectal Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01126450Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
NCT00494611A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients